1. Home
  2. RPRX vs MOH Comparison

RPRX vs MOH Comparison

Compare RPRX & MOH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPRX
  • MOH
  • Stock Information
  • Founded
  • RPRX 1996
  • MOH 1980
  • Country
  • RPRX United States
  • MOH United States
  • Employees
  • RPRX N/A
  • MOH N/A
  • Industry
  • RPRX Biotechnology: Pharmaceutical Preparations
  • MOH Medical Specialities
  • Sector
  • RPRX Health Care
  • MOH Health Care
  • Exchange
  • RPRX Nasdaq
  • MOH Nasdaq
  • Market Cap
  • RPRX 14.0B
  • MOH 16.7B
  • IPO Year
  • RPRX 2020
  • MOH 2003
  • Fundamental
  • Price
  • RPRX $33.88
  • MOH $298.78
  • Analyst Decision
  • RPRX Strong Buy
  • MOH Buy
  • Analyst Count
  • RPRX 5
  • MOH 14
  • Target Price
  • RPRX $41.60
  • MOH $354.29
  • AVG Volume (30 Days)
  • RPRX 4.6M
  • MOH 814.0K
  • Earning Date
  • RPRX 02-11-2025
  • MOH 02-05-2025
  • Dividend Yield
  • RPRX 2.60%
  • MOH N/A
  • EPS Growth
  • RPRX N/A
  • MOH 8.79
  • EPS
  • RPRX 1.91
  • MOH 20.42
  • Revenue
  • RPRX $2,263,576,000.00
  • MOH $39,164,000,000.00
  • Revenue This Year
  • RPRX $29.18
  • MOH N/A
  • Revenue Next Year
  • RPRX $9.99
  • MOH $8.18
  • P/E Ratio
  • RPRX $17.69
  • MOH $14.05
  • Revenue Growth
  • RPRX N/A
  • MOH 18.67
  • 52 Week Low
  • RPRX $24.05
  • MOH $262.32
  • 52 Week High
  • RPRX $34.16
  • MOH $423.92
  • Technical
  • Relative Strength Index (RSI)
  • RPRX 80.55
  • MOH 51.98
  • Support Level
  • RPRX $32.28
  • MOH $279.52
  • Resistance Level
  • RPRX $34.20
  • MOH $300.51
  • Average True Range (ATR)
  • RPRX 0.71
  • MOH 13.23
  • MACD
  • RPRX 0.02
  • MOH 0.72
  • Stochastic Oscillator
  • RPRX 89.40
  • MOH 56.53

About RPRX Royalty Pharma plc

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.

About MOH Molina Healthcare Inc

Molina Healthcare Inc offers healthcare plans focused on Medicaid-related solutions for low-income families and individuals. Its health plans are operated by a network of subsidiaries, each of which is licensed as a health maintenance organization (HMO). It has four segments: Medicaid, Medicare, Marketplace and Others. The Medicaid, Medicare, and Marketplace segments represent the government-funded or sponsored programs under which it offers managed healthcare services. The Other segment, which is insignificant to its consolidated results of operations, includes long-term services and supports consultative services in Wisconsin. It generates majority revenue from Medicaid segment.

Share on Social Networks: